Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(ε-caprolactone) and chitosan nanoparticles

Pharmazie

Volumn 65, Issue 12, 2010, Pages 867-870

  Cirpanli, Y ^a   Yerlikaya, F ^a   Ozturk, K ^a   Erdogar, N ^a   Launay, M ^b   Gegu, C ^b   Leturgez, T ^c   Bilensoy, E ^a   Calis, S ^a   Capan, Yilmaz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITÉ D'ANGERS   (France)

^c UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; POLYCAPROLACTONE; POLYGLACTIN; TAMOXIFEN CITRATE;

ARTICLE; BREAST CANCER; CONTROLLED RELEASE FORMULATION; GELATION; IN VITRO STUDY;

BIOLOGICAL AVAILABILITY; CHITOSAN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; ELECTROCHEMISTRY; ESTROGEN ANTAGONISTS; EXCIPIENTS; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; POLYESTERS; POLYGLYCOLIC ACID; TAMOXIFEN;

EID: 78650286732     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.0167     Document Type: Article

References (16)

1. Aktas Y, Andrieux K, Alonso MJ, Calvo P, Gursoy RN, Couvreur P, Capan Y (2005a) Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor. Int J Pharm 298: 378-383. (Pubitemid 40910746)
2. Aktas Y, Yemisci M, Andrieux K, Gursoy RN, Alonso MJ, Fernandez-Megia E, Novoa-Carballal R, Quinoa E, Riguera R, Sargon MF, Celik HH, Demir AS, Hincal AA, Dalkara T, Capan Y, Couvreur P (2005b) Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. Bioconjug Chem 16: 1503-1511.
3. Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ (1997) Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 63: 125-132.
4. Cetin M, Aktas Y, Vural I, Capan Y, Dogan LA, Duman M, Dalkara T (2007) Preparation and in vitro evaluation of bFGF-loaded chitosan nanoparticles. Drug Deliv 14: 525-529.
5. Cirpanli Y, Unlu N, Calis S, Hincal AA (2005) Formulation and in-vitro characterization of retinoic acid loaded poly (lactic-co-glycolic acid) microspheres. J Microencapsul 22: 877-889.
6. Cirpanli Y, Bilensoy E, Lale Dogan A, Calis S (2009) Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery. Eur J Pharm Biopharm 73: 82-89.
7. Jeon HJ, Jeong YI, Jang MK, Park YH, Nah JW (2000) Effect of solvent on the preparation of surfactant-free poly(DL-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. Int J Pharm 207: 99-108.
8. Karatas H, Aktas Y, Gursoy-Ozdemir Y, Bodur E, Yemisci M, Caban S, Vural A, Pinarbasli O, Capan Y, Fernandez-Megia E, Novoa-Carballal R, Riguera R, Andrieux K, Couvreur P, Dalkara T (2009) A nanomedicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection. J Neurosci 29: 13761-13769.
9. Leroueil-Le Verger M, Fluckiger L, Kim YI, Hoffman M, Maincent P (1998) Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur J Pharm Biopharm 46: 137-143.
10. Memisoglu-Bilensoy E, Vural I, Bochot A, Renoir JM, Duchene D, Hincal AA (2005) Tamoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity. J Control Release 104: 489-496.
11. Pinarbasli O, Aktas Y, Dalkara T, Andrieux K, Alonso MJ, Fernandez-Megia E, Novoa-Carballal R, Riguera R, Couvreur P, Capan Y (2009) Preparation and evaluation of alpha-phenyl-n-tert-butyl nitrone (PBN)-encapsulated chitosan and PEGylated chitosan nanoparticles. Pharmazie 64: 436-439.
12. Shive MS, Anderson JM (1997) Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 28: 5-24.
13. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A (2004) Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int J Pharm 278: 1-23.
14. Vila A, Sanchez A, Janes K, Behrens I, Kissel T, Vila Jato JL, Alonso MJ (2004) Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm 57: 123-131.
15. Vural I, Memisoglu-Bilensoy E, Renoir JM, Bochot A, Duchene D, Hincal AA (2005) Transcription efficiency of tamoxifen citrate loaded β-cyclodextrin nanoparticles. J Drug Del Sci Technol 15: 339-342.
16. Yerlikaya F, Launay M, Gegu C, Leturgez T, Memisoglu-Bilensoy E, Calis S, Capan Y (2009) Analytical method development and validation of tamoxifen citrate using normal phase high performance liquid chromatography. Proceedings of the 3rd BBBB-Bosphorus International Conference on Pharmaceutical Sciences.